SpyGlass Pharma

(NASDAQ) SGP

Current Price$20.29

Market Cap$674.35M

Since IPO (2026)-24%

5 YearN/A

1 YearN/A

1 Month-15%

SpyGlass Pharma Financials at a Glance

Market Cap

$674.35M

Revenue (TTM)

$0.00

Net Income (TTM)

-$43.60

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.59 (Low)

Dividend

$0.00

Beta (Volatility)

0.59 (Low)

Price

$20.29

Volume

14,634.104

Open

$20.28

Price

$20.29

Volume

14,634.104

Open

$20.28

Previous Close

$20.17

Daily Range

$19.46 - $20.57

52-Week Range

$16.00 - $32.44

Dividend

$0.00

Beta (Volatility)

0.59 (Low)

Price

$20.29

Volume

14,634.104

Open

$20.28

Previous Close

$20.17

Daily Range

$19.46 - $20.57

52-Week Range

$16.00 - $32.44

SGP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SpyGlass Pharma

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Patrick Mooney

Website

www.spyglasspharma.com

Headquarters

Aliso Viejo, CA 92656, US

SGP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-12%

Return on Assets

-10%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$674.35M

Shares Outstanding

33.43M

Volume

14.63K

Avg. Volume

98.60K

Financials (TTM)

Gross Profit

-$612.00K

Operating Income

-$41.45M

EBITDA

-$40.84M

Operating Cash Flow

-$32.70M

Capital Expenditure

-$789.00K

Free Cash Flow

-$33.49M

Cash & ST Invst.

$107.44M

Total Debt

$1.58M

SpyGlass Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$318.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$674.35M

N/A

Market Cap/Employee

$452.89K

N/A

Employees

1,489

N/A

Net Income

-$13.82M

N/A

EBITDA

-$15.09M

N/A

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$249.40M

N/A

Accounts Receivable

$653.00K

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.61M

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-10.21%

N/A

Return on Invested Capital

-11.54%

N/A

Free Cash Flow

-$14.22M

N/A

Operating Cash Flow

-$13.54M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,523.78+0.00%

^DJIDJI

^DJIDJI$50,649.08+0.00%

^IXICNASDAQ

^IXICNASDAQ$26,683.17+0.00%

BTCBitcoin

BTCBitcoin$74,768.00-0.02%

AAPLAAPL

AAPLAAPL$310.82+0.01%

AMZNAMZN

AMZNAMZN$270.07+0.02%

GOOGGOOG

GOOGGOOG$388.40+0.01%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CZRCaesars Entertainment

CZRCaesars Entertainment$29.11+0.01%

NOKNokia

NOKNokia$15.50-0.01%

RCATRed Cat

RCATRed Cat$13.66+0.28%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.71-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.33+0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$83.18+0.02%

SIDUSidus Space

SIDUSidus Space$5.10-0.16%

Questions About SGP

What is the current price of SpyGlass Pharma?

SpyGlass Pharma is trading at $20.48 per share.

What is the 52-week range for SpyGlass Pharma?

Over the past 52 weeks, SpyGlass Pharma has traded between $16.00 and $32.44.

How much debt does SpyGlass Pharma have?

As of the most recent reporting period, SpyGlass Pharma reported total debt of $1.61M.

How much cash does SpyGlass Pharma have on hand?

SpyGlass Pharma reported $238.90M in cash and cash equivalents in its most recent financial results.

What is SpyGlass Pharma’s dividend yield?

SpyGlass Pharma does not currently have a dividend yield.

SpyGlass Pharma

SpyGlass Pharma Financials at a Glance

SGP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About SpyGlass Pharma

SGP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

SpyGlass Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SGP

What is the current price of SpyGlass Pharma?

What is the 52-week range for SpyGlass Pharma?

How much debt does SpyGlass Pharma have?

How much cash does SpyGlass Pharma have on hand?

What is SpyGlass Pharma’s dividend yield?

Premium Investing Services